Advertisement
Advertisement

SOPH

SOPH logo

SOPHiA GENETICS SA Ordinary Shares

4.88
USD
Sponsored
-0.17
-3.37%
May 22, 16:00 UTC -4
Closed
exchange

After-Market

4.89

+0.01
+0.31%

SOPH Earnings Reports

Positive Surprise Ratio

SOPH beat 10 of 20 last estimates.

50%

Next Report

Date of Next Report
Aug 03, 2026
Estimate for Q2 26 (Revenue/ EPS)
$22.06M
/
-$0.22
Implied change from Q1 26 (Revenue/ EPS)
+1.70%
/
-18.52%
Implied change from Q2 25 (Revenue/ EPS)
+20.38%
/
-33.33%

SOPHiA GENETICS SA Ordinary Shares earnings per share and revenue

On May 05, 2026, SOPH reported earnings of -0.27 USD per share (EPS) for Q1 26, missing the estimate of -0.23 USD, resulting in a -13.83% surprise. Revenue reached 21.69 million, compared to an expected 20.81 million, with a 4.23% difference. The market reacted with a -4.16% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 5 analysts forecast an EPS of -0.22 USD, with revenue projected to reach 22.06 million USD, implying an decrease of -18.52% EPS, and increase of 1.70% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Talkspace, Inc. Common Stock
Report Date
May 11, 2026 For Q1 26
Estimate
$0.02
Actual
-$0.04
Surprise
-269.49%
logo
CapsoVision, Inc. Common Stock
Report Date
May 14, 2026 For Q1 26
Estimate
-$0.13
Actual
-$0.15
Surprise
-12.02%
logo
Nyxoah SA Ordinary Shares
Report Date
May 12, 2026 For Q1 26
Estimate
-$0.50
Actual
-$0.36
Surprise
+27.03%
logo
MDxHealth SA Ordinary Shares
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.15
Actual
-$0.17
Surprise
-9.68%
logo
Insight Molecular Diagnostics Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.26
Actual
-$0.12
Surprise
+55.01%
logo
Neuraxis, Inc.
Report Date
May 12, 2026 For Q1 26
Estimate
-$0.19
Actual
-$0.18
Surprise
+7.12%
logo
Doximity, Inc.
Report Date
May 13, 2026 For Q1 26
Estimate
$0.28
Actual
$0.26
Surprise
-9.97%
logo
Doximity, Inc.
Report Date
May 13, 2026 For Q4 26
Estimate
$0.28
Actual
$0.26
Surprise
-9.97%
logo
Heartflow, Inc. Common Stock
Report Date
May 14, 2026 For Q1 26
Estimate
-$0.19
Actual
-$0.23
Surprise
-20.10%
logo
Heartbeam, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.14
Actual
-$0.12
Surprise
+14.77%
FAQ
For Q1 2026, SOPHiA GENETICS SA Ordinary Shares reported EPS of -$0.27, missing estimates by -13.83%, and revenue of $21.69M, 4.23% above expectations.
The stock price moved down -4.16%, changed from $5.29 before the earnings release to $5.07 the day after.
The next earning report is scheduled for Aug 03, 2026.
Based on 5 analysts, SOPHiA GENETICS SA Ordinary Shares is expected to report EPS of -$0.22 and revenue of $22.06M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement